While c-Myc knockdown significantly inhibited the proliferation of ASMCs derived from both healthy and asthma donors, JQ1 treatment had no effect on c-Myc mRNA levels, a reported target of BRD4 [74,75]. The gene discussed is MYC; the disease is asthma.